PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1750 participants.
Also called NCT05934487
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 1,750 participants
- Sponsor
- Endotronix, Inc.
- Registry
-
NCT05934487
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Belgium, Ireland
- Registry status
- Recruiting
Technical summary
Registry record NCT05934487. Randomized; double masking; primary purpose diagnostic. Start 2023-11-29 (actual); primary completion 2028-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- Condition
- Heart Failure NYHA Class II
- Condition
- Heart Failure NYHA Class III
- Condition
- Heart Failure
- Intervention (Device)
- Cordella™ Pulmonary Artery Sensor System
- Lead sponsor
- Endotronix, Inc.
Record details
- Record id
cardio:ct-nct05934487- Content hash
5ef6e4cb290b729aba8e31fbee001753ce3fd79fea362b6ae11ba01b68a1e098